David Hung’s Nuvation Bio seals merger with blank cheque firm PanaceaTwo years after quietly forming cancer start-up Nuvation Bio, ex-Axovant and Medivation CEO David Hung has agreed a Share XDavid Hung’s Nuvation Bio seals merger with blank cheque firm Panaceahttps://pharmaphorum.com/news/david-hungs-nuvation-bio-seals-merger-with-blank-cheque-firm-panacea/
